Mycobacterium tuberculosis Ser/Thr Protein Kinase B Mediates an Oxygen-Dependent Replication Switch

PLoS Biology

Volumn 12, Issue 1, 2014, Pages

  Ortega, Corrie ^a,b   Liao, Reiling ^a   Anderson, Lindsey N ^c   Rustad, Tige ^a   Ollodart, Anja R ^a   Wright, Aaron T ^c   Sherman, David R ^a,b   Grundner, Christoph ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBAZOLES; GENE EXPRESSION REGULATION, BACTERIAL; INDOLE ALKALOIDS; MYCOBACTERIUM TUBERCULOSIS; OXYGEN; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SERINE; SIGNAL TRANSDUCTION; THREONINE;

EID: 84893754328     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001746     Document Type: Article

References (50)

1. World Health Organization. (2013) Global tuberculosis report 2013. http://www.who.int/tb/publications/global_report/en/index.html.
2. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, et al. (2000) Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med 162: 460-464.
3. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, et al. (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545-550.
4. Getahun H, Gunneberg C, Granich R, Nunn P, (2010) HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50 Suppl 3: S201-S207.
5. Rustad TR, Sherrid AM, Minch KJ, Sherman DR, (2009) Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol 11: 1151-1159.
6. Novy FG, Soule MH, (1925) Microbic respiration. II. Repiration of the tubercle bacillus. J Infect Dis 36: 168.
7. Rich AR, Follis RH Jr, (1942) The effect of low oxygen tension upon the development of experimental tuberculosis. Bull Johns Hopkins Hosp 71: 345-363.
8. Wayne LG, (1977) Synchronized replication of Mycobacterium tuberculosis. Infect Immun 17: 528-530.
9. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, et al. (2006) Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8: 218-232.
10. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76: 2333-2340.
11. Adler JJ, Rose DN (1996) Transmission and pathogenesis of tuberculosis. In: Rom WN, Garay SM, editors. Tuberculosis. Boston: Little, Brown and Co. pp. 129-140.
12. Boshoff HI, Barry CE 3rd, (2005) Tuberculosis- metabolism and respiration in the absence of growth. Nat Rev Microbiol 3: 70-80.
13. Flynn JL, Chan J, (2001) Tuberculosis: latency and reactivation. Infect Immun 69: 4195-4201.
14. Gomez JE, McKinney JD, (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84: 29-44.
15. Parrish NM, Dick JD, Bishai WR, (1998) Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 6: 107-112.
16. Alber T, (2009) Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr protein kinases. Curr Opin Struct Biol 19: 650-657.
17. Greenstein AE, Grundner C, Echols N, Gay LM, Lombana TN, et al. (2005) Structure/function studies of Ser/Thr and Tyr protein phosphorylation in Mycobacterium tuberculosis. J Mol Microbiol Biotechnol 9: 167-181.
18. Kang CM, Abbott DW, Park ST, Dascher CC, Cantley LC, et al. (2005) The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape. Genes Dev 19: 1692-1704.
19. Gee CL, Papavinasasundaram KG, Blair SR, Baer CE, Falick AM, et al. (2012) A phosphorylated pseudokinase complex controls cell wall synthesis in mycobacteria. Sci Signal 5: ra7.
20. Prisic S, Dankwa S, Schwartz D, Chou MF, Locasale JW, et al. (2010) Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases. Proc Natl Acad Sci U S A 107: 7521-7526.
21. Rustad TR, Harrell MI, Liao R, Sherman DR, (2008) The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3: e1502 doi:10.1371/journal.pone.0001502.
22. Sherrid AM, Rustad TR, Cangelosi GA, Sherman DR, (2010) Characterization of a Clp protease gene regulator and the reaeration response in Mycobacterium tuberculosis. PLoS ONE 5: e11622 doi:10.1371/journal.pone.0011622.
23. Fernandez P, Saint-Joanis B, Barilone N, Jackson M, Gicquel B, et al. (2006) The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth. J Bacteriol 188: 7778-7784.
24. Corper HJ, Cohn ML, (1951) The viability and virulence of old cultures of tubercle bacilli; studies on 30-year-old broth cultures maintained at 37 degrees C. Tubercle 32: 232-237.
25. Wayne LG, Hayes LG, (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64: 2062-2069.
26. Fischer JJ, Graebner Baessler OY, Dalhoff C, Michaelis S, Schrey AK, et al. (2010) Comprehensive identification of staurosporine-binding kinases in the hepatocyte cell line HepG2 using Capture Compound Mass Spectrometry (CCMS). J Proteome Res 9: 806-817.
27. Wright AT, Cravatt BF, (2007) Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo. Chem Biol 14: 1043-1051.
28. Ansong C, Ortega C, Payne SH, Haft DH, Chauvigne-Hines LM, et al. (2013) Identification of widespread adenosine nucleotide binding in Mycobacterium tuberculosis. Chem Biol 20: 123-133.
29. Patricelli MP, Szardenings AK, Liyanage M, Nomanbhoy TK, Wu M, et al. (2007) Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 46: 350-358.
30. Smith RD, Anderson GA, Lipton MS, Pasa-Tolic L, Shen Y, et al. (2002) An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics 2: 513-523.
31. BEI Resources. (2013). http://www.beiresources.org.
32. Chao JD, Papavinasasundaram KG, Zheng X, Chavez-Steenbock A, Wang X, et al. (2010) Convergence of Ser/Thr and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis. J Biol Chem 285: 29239-29246.
33. Galagan JE, Minch K, Peterson M, Lyubetskaya A, Azizi E, et al. (2013) The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499: 178-183.
34. van Kessel JC, Hatfull GF, (2007) Recombineering in Mycobacterium tuberculosis. Nat Methods 4: 147-152.
35. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
36. Duran R, Villarino A, Bellinzoni M, Wehenkel A, Fernandez P, et al. (2005) Conserved autophosphorylation pattern in activation loops and juxtamembrane regions of Mycobacterium tuberculosis Ser/Thr protein kinases. Biochem Biophys Res Commun 333: 858-867.
37. Barthe P, Mukamolova GV, Roumestand C, Cohen-Gonsaud M, (2010) The structure of PknB extracellular PASTA domain from mycobacterium tuberculosis suggests a ligand-dependent kinase activation. Structure 18: 606-615.
38. Mir M, Asong J, Li X, Cardot J, Boons GJ, et al. (2011) The extracytoplasmic domain of the Mycobacterium tuberculosis Ser/Thr kinase PknB binds specific muropeptides and is required for PknB localization. PLoS Pathog 7: e1002182 doi: 10.1371/journal.ppat.1002182.
39. Shah IM, Laaberki MH, Popham DL, Dworkin J, (2008) A eukaryotic-like Ser/Thr kinase signals bacteria to exit dormancy in response to peptidoglycan fragments. Cell 135: 486-496.
40. Szekely R, Waczek F, Szabadkai I, Nemeth G, Hegymegi-Barakonyi B, et al. (2008) A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling. Immunol Lett 116: 225-231.
41. Lougheed KE, Osborne SA, Saxty B, Whalley D, Chapman T, et al. (2011) Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents. Tuberculosis (Edinb) 91: 277-286.
42. Chapman TM, Bouloc N, Buxton RS, Chugh J, Lougheed KE, et al. (2012) Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. Bioorg Med Chem Lett 22: 3349-3353.
43. Ruan BF, Zhu HL, (2012) The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development. Curr Med Chem 19: 2652-2664.
44. Wards BJ, Collins DM, (1996) Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol Lett 145: 101-105.
45. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, et al. (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198: 705-713.
46. Vandal OH, Nathan CF, Ehrt S, (2009) Acid resistance in Mycobacterium tuberculosis. J Bacteriol 191: 4714-4721.
47. Zimmer JS, Monroe ME, Qian WJ, Smith RD, (2006) Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev 25: 450-482.
48. Yates JR 3rd, Eng JK, McCormack AL, Schieltz D, (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67: 1426-1436.
49. Stanley JR, Adkins JN, Slysz GW, Monroe ME, Purvine SO, et al. (2011) A statistical method for assessing peptide identification confidence in accurate mass and time tag proteomics. Anal Chem 83: 6135-6140.
50. Polpitiya AD, Qian WJ, Jaitly N, Petyuk VA, Adkins JN, et al. (2008) DAnTE: a statistical tool for quantitative analysis of-omics data. Bioinformatics 24: 1556-1558.